Your browser doesn't support javascript.
loading
Anaplastic Lymphoma Kinase Mutation (ALK F1174C) in Small Cell Carcinoma of the Prostate and Molecular Response to Alectinib.
Carneiro, Benedito A; Pamarthy, Sahithi; Shah, Ami N; Sagar, Vinay; Unno, Kenji; Han, HuiYing; Yang, Ximing J; Costa, Rubens B; Nagy, Rebecca J; Lanman, Richard B; Kuzel, Timothy M; Ross, Jeffrey S; Gay, Laurie; Elvin, Julia A; Ali, Siraj M; Cristofanilli, Massimo; Chae, Young K; Giles, Francis J; Abdulkadir, Sarki A.
Afiliação
  • Carneiro BA; Division of Hematology/Oncology, Lifespan Cancer Institute, the Warren Alpert Medical School, Brown University, Providence, Rhode Island. Benedito.carneiro@lifespan.org.
  • Pamarthy S; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Shah AN; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Sagar V; Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Unno K; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Han H; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Yang XJ; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Costa RB; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Nagy RJ; The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Lanman RB; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Kuzel TM; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Ross JS; Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
  • Gay L; Guardant Health, Inc., Redwood City, California.
  • Elvin JA; Guardant Health, Inc., Redwood City, California.
  • Ali SM; Rush University Medical Center, Division of Hematology/Oncology, Chicago, Illinois.
  • Cristofanilli M; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Chae YK; Upstate Medical University, Syracuse, New York.
  • Giles FJ; Foundation Medicine Inc., Cambridge, Massachusetts.
  • Abdulkadir SA; Foundation Medicine Inc., Cambridge, Massachusetts.
Clin Cancer Res ; 24(12): 2732-2739, 2018 06 15.
Article em En | MEDLINE | ID: mdl-29559559
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Neoplasias da Próstata / Carbazóis / Carcinoma de Células Pequenas / Inibidores de Proteínas Quinases / Quinase do Linfoma Anaplásico / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Neoplasias da Próstata / Carbazóis / Carcinoma de Células Pequenas / Inibidores de Proteínas Quinases / Quinase do Linfoma Anaplásico / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos